Coronavirus drug proves effective against virus, company says

Coronavirus test swab

Biotech Company Gilead Sciences says government study shows its remdesivir drug helps patients recover from coronavirus faster.

American biotech company Gilead Sciences announced that its new experimental drug has been proven effective against the novel coronavirus according to a study by the US government.

The drug, remdesivir, is the first treatment for the coronavirus to pass the study conducted by the National Institutes of Health. The study tested the effectiveness of the drug compared to normal care in 800 coronavirus patients around the world and measured the differences in recovery time.

Remdesivir was developed to combat other diseases which are caused by similar viruses such as SARS and MERS. The drug has been closely watched by healthcare professionals as a possible means to mitigate the coronavirus crisis. The study could pave the way for the US Food and Drug Administration to fast-track an emergency approval of remdesivir. No country has currently approved the use of the drug.

Gilead Sciences shares rose 5.7% in response to the announcement of the study while the S&P 500 rose 2.4%.

Read more of this story

(Visited 99 times, 1 visits today)
About Cholo Brooks 15636 Articles
Joel Cholo Brooks is a Liberian journalist who previously worked for several international news outlets including the BBC African Service. He is the CEO of the Global News Network which publishes two local weeklies, The Star and The GNN-Liberia Newspapers. He is a member of the Press Union Of Liberia (PUL) since 1986, and several other international organizations of journalists, and is currently contributing to the South Africa Broadcasting Corporation as Liberia Correspondent.